Full Length Research Paper
References
|
Adami HO, Ponten J, Sparen P, Bergstrom R, Gustafsson L, Friberg LG (1994). Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening. Cancer 73(1):140-147. |
|
|
Arbyn M, Sankaranarayanan R, Muwonge R, Keita N, Dolo A, Mbalawa CG, Nouhou H, Sakande B, Wesley R, Somanathan T, Sharma A (2008). Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int. J. Cancer 123(1):153-160. |
|
|
Ausubel FM, Brent R, Kingston RE, Moore DD (1999). Short Protocols in Molecular Biology. New York: Gre Pub. Asso and Wil. Inter. Available at: |
|
|
Djigma FW, Ouedraogo C, Karou DS, Sagna T, Bisseye C, Zeba M, Ouermi D, Gnoula C, Pietra V, Ghilat-Avoid-Belem NW, Sanogo K (2011). Prevalence and genotype characterization of human papillomaviruses among HIV-seropositive in Ouagadougou, Burkina Faso. Act. Trop. 117(3):202-206 |
|
|
GLOBOCAN (2008). Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. Available at: |
|
|
Globocan Cancer Fact sheets (2012). Cervical Cancer. Available online: View. Accessed 11 Aug 2015. |
|
|
Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ (2000). Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38(1):357-361 |
|
|
Horo A, Jaquet A, Ekouevi DK, Toure B, Coffie PA, Effi B, Messou E, Jacquet A, Horo A, Charbonneau V, Ekouevi DK, Roncin L, Toure B, Coffie P, Minga A, Sasco AJ, Garrigue I, Fleury H, Dabis F (2010), for the IeDEA West Africa collaboration. Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Cote d'Ivoire 2010. Br. J. Cancer 2012:1-8. |
|
|
Lazcano-Ponce EC, de Ruíz PA, López-Carrillo L, Nájera-Aguilar P, Avila-Ceniceros R, Escandón-Romero C, Cisneros MT, Hernández-Avila M (1997). Validity and reproducibility of cytologic diagnosis in a sample of cervical cancer screening centers in Mexico. Act. Cytol. 41(2):277-284. |
|
|
Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (1990). Report on a Workshop of the UICC Project on Evaluation of Screening for Cancer. Int. J. Cancer. 46(5):761-769. |
|
|
Miller AB, Sankaranarayanan R, Bosch FX, Sepulveda C (2003). Can screening for cervical cancer be improved, especially in developing countries? Int. J. Cancer 107(3):337-340 |
|
|
Minga A, Moh R, Kone M, Dabis F, Sasco AJ (2012) Cervical cancer screening by visual inspection in Cote d'Ivoire, operational and clinical aspects according to HIV status. BMC Public Health 12(1):237. |
|
|
Moussavou PB, Koumakpayi IH, Andriniaina, Nkili-Meyong A, Labouba I, Bisvigou U, Chansi JK, Engohan-Aloghe C, Dissanami F, Ambounda N, Delannoy-Vieillard AS, Diancourt L, Nkoghe D, Leroy EM, Belembaogo E and Berthet N (2016). Molecular analysis of human Papillomavirus detected among women positive for cervical lesions by visual inspection with acetic acid/Lugol's iodine (VIA/VILI) in Libreville, Gabon. Infect. Agent Cancer 11:50 |
|
|
Ngoma T, Muwonge R, Mwaiselage J, Kawegere J, Bukori P, Sankaranarayanan R (2010). Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania. Int. J. Gynaecol. Obstet. 109(2):100-104. |
|
|
Okolo C, Franceschi S, Adewole I, Thomas JO, Follen M, Snijders PJ, Meijer CJ, Clifford GM (2010). Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Infect Agent Cancer 5(1):24 |
|
|
Piras F, Piga M, De Montis A, Zannou AR, Minerba L, Perra MT, Murtas D, Atzori M, Pittau M, Maxia C, Sirigu P (2011). Prevalence of Human Papillomavirus infection in women in Benin, West Africa. Virol. J. 8:514. |
|
|
Sankaranarayanan R, Budukh AM, Rajkumar R (2001). Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull. World Health Organization 79(10):954-962. |
|
|
Sankaranarayanan R, Wesley R, Thara S, Dhakad N, Chandralekha B, Sebastian P, Chithrathara K, Parkin DM. Nair MK (2003). Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala. Ind. Int. J. Cancer 106(3):404-408. |
|
|
Sankaranarayanan R, Wesley RS (2003). A Practical Manual on Visual Screening for Cervical Neoplasia. IARC Tech. Pub. 41. IARC Press: Lyon. |
|
|
Teguete I, Muwonge R, Traore C, Dolo A, Bayo S, Sankaranarayanan R (2012) . Can visual cervical screening be sustained in routine health services? Experience from Mali, Africa. BJOG 119:220-226. |
|
|
Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, Oladepo O, Smith JS, Arslan A, Munoz N, Snijders PJ, Meijer CJ, Franceschi S (2004) Prevalence of papillomavirus infection in women in Ibadan, Nigeria: A population-based study. Br. J. Cancer 90(3):638-645 |
|
|
Tsakogiannis D, Diamantidou V, Toska E, Kyriakopoulou Z, Dimitriou TG, Ruether IGA, Gortsilas P, Markoulatos P (2015). Multiplex PCR assay for the rapid identification of human papillomavirus genotypes 16, 18, 45, 35, 66, 33, 51, 58, and 31 in clinical samples. Arch. Virol.160(1):207-214. |
|
|
University of Zimbabwe/JHPIEGO Cervical Cancer Project (1999). Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. Lancet 353(9156):869-873. |
|
|
zur Hausen H (2009). Papillomaviruses in the causation of human cancers¬¬¬-a brief historical account. Virology 384(2):260-265. |
|
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
